+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
From
Alcohol Addiction - Global Clinical Trials Review, 2022 - Product Thumbnail Image

Alcohol Addiction - Global Clinical Trials Review, 2022

  • Clinical Trials
  • February 2022
  • 461 Pages
  • Global
From
Hyperinsulinemia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hyperinsulinemia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 93 Pages
  • Global
From
Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Diabetic Foot Infection (DFI) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 98 Pages
  • Global
From
Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Postherpetic Neuralgia - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 283 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more